Aura Biosciences Inc (United States) is listed on the Nasdaq and has a market capitalization of $769.73 million, with shareholders equity totaling $287.43 million.
The company employs approximately 113 people and operates in the Other sector, within the Other industry.
Over the past 12 months, Aura Biosciences Inc reported $- in revenue, generating net income of $-136.95 million.
Key financial metrics include a P/E ratio of -5.62, a price-to-book (P/B) ratio of 2.68, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker AURA.